Because they're not making products for human consumption, they're not subject to rules about what they can offer and when, based on shortages, drug approvals, or patent status
In the US, obesity rates declined from nearly 40% in 2021 to 37% in 2025, according to a large Gallup poll
Additionally, improved glycemic control with GLP-1 RAs in T2DM patients may reduce glycosuria, a process known as glycemic buffering, which reduces caloric loss through urine and offsets part of the energy deficit induced by treatment [43,44,45]
Clinical trial treatment durations Is retatrutide a fixed "cycle"
Clues from a two-step mendelian randomized study
This holistic approach to treatment underscores the importance of addressing both the physical and mental aspects of obesity, paving the way for a more sustainable and fulfilling lifestyle change